NAPLES, FL – Stemtech (OTCID: STEK) has shared a new scientific research framework from Dr. Zahoorudin, MBBS, M.D. He is a board-certified Diplomate of the American Academy of Stem Cell Physicians (AASCP), USA. The framework explores how advances in regenerative biology can deepen understanding of Stemtech’s stem cell nutrition platform.
Stemtech pioneered nutritional support for the body’s endogenous stem-cell system. Its core concept is Release → Circulate → Migrate.
Dr. Zahoorudin’s review shows modern research now allows deeper investigation of this idea. It moves beyond bone-marrow mobilization. The expanded view includes nutrient sensing, mitochondrial biology, nitric-oxide signaling, circulating progenitor cells, and tissue-resident regenerative niches.
“Stemtech was ahead of its time in recognizing that nutrition could interact with the body’s own regenerative biology. The next scientific question is no longer only how many stem cells we can release from bone marrow.Â
It is how nutrition may influence the entire regenerative environment — from cellular energy and vascular signaling to mobilization, homing and the tissue niches where regeneration actually occurs,” said Dr. Zahoorudin.
Emerging studies support the proposed model. Human trials report increased circulating CD34+ progenitor cells and higher CXCR4 homing receptor expression after fucoidan intake.
Dietary inorganic nitrate has also been shown to raise circulating angiogenic and progenitor-cell populations. This creates a possible link between nutrition, nitric oxide, vascular signaling, and the body’s natural regenerative responses.
Modern regenerative biology further shows important tissue-resident stem cell populations outside the bone marrow. Adipose tissue holds stromal and progenitor cells. Skeletal muscle contains satellite stem cells that aid muscle repair and adaptation.
These findings raise a broader research question: Can nutritional compounds influence both circulating cells and the stem-cell niches that guide tissue renewal?
Dr. Zahoorudin suggests confirming Stemtech’s original model through a fuller scientific sequence:
Activate → Release → Circulate → Home → Regenerate → Renew
Key pathways under study include AMPK, SIRT1, PGC-1α, mitochondrial function, eNOS/nitric oxide, and SDF-1/CXCR4 signaling.
Stemtech’s current portfolio already features bioactive ingredients such as fucoidan, resveratrol, curcumin, Astragalus, Cordyceps, polyphenols, and marine botanicals. This creates clear opportunities for systematic research on how these formulations interact with markers of endogenous regenerative biology.
“The opportunity is not to replace Stemtech’s original science, but to build upon it. Release, Circulation and Migration were the beginning. Modern science now gives us the tools to investigate Activation, Homing, Vascular Signaling, Cellular Energy and tissue-specific regenerative niches as parts of one interconnected biological system,” Dr. Zahoorudin stated.
Dr. Zahoorudin emphasizes that any effects on specific tissue stem-cell populations must be tested experimentally. Future studies should measure which molecular pathways and regenerative cell populations respond to particular nutritional formulations.
The core concept can be summarized as:
Exercise / Fasting / Nutritional Signal → AMPK/SIRT1 → Lipolysis + Adipose-Niche Remodeling → CD34+ Adipose Progenitor Changes → Potential Cell Trafficking?
This approach links Stemtech’s pioneering stem cell nutrition platform with metabolic signaling, vascular regeneration, longevity biology, and tissue-specific regenerative medicine. It may help define the next chapter of stem cell nutrition science.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
“Stemtech was built on a simple but powerful idea: that nutrition can support the body’s own renewal system. Dr. Zahoorudin’s work honors the Release → Circulate → Migrate science that defined our company, and it points us toward the questions that can define our next chapter. We intend to continue to pursue this as a disciplined research direction — testing and measuring — so that our distributors, customers and shareholders can be confident that the future of stem cell nutrition is being built on rigorous, credible science.”
Dr. Zahoorudin, MBBS, M.D., is a board-certified Diplomate of the American Academy of Stem Cell Physicians (AASCP), USA. He credits Stemtech’s stem cell nutrition science with launching his career in regenerative medicine.
He has used Stemtech stemceutical™ products in clinical practice for over sixteen years and serves on the Stemtech Life Sciences Advisory Board.
Stemtech Corporation is a publicly traded wellness company specializing in stemceuticals™. These are all-natural, plant-based nutritional solutions designed to support the body’s natural regenerative processes.
Founded in 2018 after acquiring operations from Stemtech International, Inc. (established in 2005), the company has a long history of innovation in stem cell nutrition and wellness science. As the pioneer in stem cell nutrition — spanning nutritional, skin care, and pet health products — Stemtech is well positioned to grow in the global wellness industry.
There are no reviews yet. Be the first one to write one.
